This activity is expired and is no longer available for CME credit.

CME

This activity is supported by an educational grant from Genentech, Inc.

Avoiding “Loss of Chance”…Improving the Screening, Treatment, and Referral of Patients with Diabetic Retinopathy

Avoiding “Loss of Chance”…Improving the Screening, Treatment, and Referral of Patients with Diabetic Retinopathy

This activity is supported by an educational grant from Genentech, Inc.

Overview

Author(s)/Faculty: Rishi P. Singh, MD; Vivian A. Fonseca, MD, FRCP; Sangeeta R. Kashyap, MD; Jennifer K. Sun, MD, MPH
Source: Healio - Endocrinology Education Lab
Type: MultimediaArticles/Items: 2
Release Date: 7/24/2015Expiration Date: 7/23/2016
Credit Type: CMENumber of Credits: 2
Cost: FreeProvider: Vindico Medical Education
Despite a number of effective treatment options, diabetic eye disease is a leading cause of vision loss in the United States, in part because many patients are not identified as needing therapy. In addition to counseling patients on the impact glucose control has on maintaining vision, clinicians should emphasize the need for vision screening among patients with diabetes. Early detection offers the best long-term visual outcomes and is even more important with a new treatment approved for the management of diabetic retinopathy and another being considered. In this activity, leading endocrinologists and retina specialists will discuss preventive measures that clinicians can take to delay or prevent vision loss in patients with diabetes and review the latest data on treatment options for patients with diabetic eye disease.

CME Information

page 1 of 5